These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
625 related items for PubMed ID: 29893751
1. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival. Kim HR, Seo M, Nah YW, Park HW, Park SH. Nucl Med Commun; 2018 Jul; 39(7):691-698. PubMed ID: 29893751 [Abstract] [Full Text] [Related]
2. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS. Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707 [Abstract] [Full Text] [Related]
3. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer. Sasaki K, Kawasaki H, Sato M, Koyama K, Yoshimi F, Nagai H. Dig Surg; 2017 May; 34(1):60-67. PubMed ID: 27454870 [Abstract] [Full Text] [Related]
4. The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis. Jung NY, Kim SH, Kang BJ, Park SY, Chung MH. Breast Cancer; 2016 Sep; 23(5):712-7. PubMed ID: 26219608 [Abstract] [Full Text] [Related]
8. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer. Bae SU, Won KS, Song BI, Jeong WK, Baek SK, Kim HW. Cancer Imaging; 2018 Sep 14; 18(1):32. PubMed ID: 30217167 [Abstract] [Full Text] [Related]
9. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Asagi A, Ohta K, Nasu J, Tanada M, Nadano S, Nishimura R, Teramoto N, Yamamoto K, Inoue T, Iguchi H. Pancreas; 2013 Jan 14; 42(1):11-9. PubMed ID: 22699206 [Abstract] [Full Text] [Related]
10. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer. Shigemoto Y, Suga K, Matsunaga N. Ann Nucl Med; 2016 May 14; 30(4):287-97. PubMed ID: 27007128 [Abstract] [Full Text] [Related]
11. Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer. Albano D, Familiari D, Gentile R, Scalisi S, Midiri F, Messina M, Spada M, Fornito MC, Galia M, Midiri M, Alongi P. Nucl Med Commun; 2018 Aug 14; 39(8):741-746. PubMed ID: 29782393 [Abstract] [Full Text] [Related]
12. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study. Zhai X, Guo Y, Qian X. Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109 [Abstract] [Full Text] [Related]
14. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer. Manabe O, Hattori N, Hirata K, Itoh K, Hosokawa M, Takahashi H, Oyama-Manabe N, Tamaki N. J Nucl Med; 2013 May 02; 54(5):670-6. PubMed ID: 23516310 [Abstract] [Full Text] [Related]
16. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study. Caobelli F, Alongi P, Evangelista L, Picchio M, Saladini G, Rensi M, Geatti O, Castello A, Laghai I, Popescu CE, Dolci C, Crivellaro C, Seghezzi S, Kirienko M, De Biasi V, Cocciolillo F, Quartuccio N, Young AIMN Working Group. Eur J Nucl Med Mol Imaging; 2016 Mar 02; 43(3):404-13. PubMed ID: 26381775 [Abstract] [Full Text] [Related]
17. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study. Shinya T, Otomi Y, Kubo M, Kinoshita M, Takechi K, Uyama N, Yamanaka M, Terazawa K, Toba H, Bando Y, Otsuka H, Harada M. Ann Nucl Med; 2019 Jun 02; 33(6):414-423. PubMed ID: 30911883 [Abstract] [Full Text] [Related]
20. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, Lee JD. J Nucl Med; 2014 Jun 02; 55(6):898-904. PubMed ID: 24711649 [Abstract] [Full Text] [Related] Page: [Next] [New Search]